AFP and hemoglobin measurement: When combined, AFP, ctDNA, and SUA form a robust diagnostic framework, enhancing the ability to stratify risk, monitor disease progression, and evaluate treatment efficacy in HB, offering clinicians a comprehensive approach to patient management